SVB Financial Group
- SEC CIK
- 0000719739
- Latest filing
- Nov 10, 2025
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 11, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 24
- −4 vs. Q1 2023
- Portfolio value
- $52.9M
- +$638.2K (+1.2%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| COINCoinbase Global, Inc. | COM CL A | 406,973 | $29.1M | 55.0% | 00.0% | Unchanged | History |
| ROOTRoot, Inc. | CL A NEW | 783,012 | $7.00M | 13.2% | 00.0% | Unchanged | History |
| OKTAOkta, Inc. | CL A | 99,872 | $6.93M | 13.1% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 33,849 | $2.43M | 4.6% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 35,353 | $1.47M | 2.8% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 21,799 | $1.01M | 1.9% | −7,267−25.0% | Reduced | History |
| CMAXCareMax, Inc. | COM CL A | 300,000 | $933.0K | 1.8% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 127,068 | $889.5K | 1.7% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 16,173 | $824.8K | 1.6% | 00.0% | Unchanged | History |
| PLPlanet Labs PBC | COM CL A | 172,097 | $554.2K | 1.0% | 00.0% | Unchanged | History |
| ROVRRover Group, Inc. | COMMON STOCK | 105,534 | $518.2K | 1.0% | 00.0% | Unchanged | History |
| GLBEGlobal-E Online Ltd. | SHS | 5,114 | $209.4K | 0.4% | +5,114 | New | History |
| GBIOGeneration Bio Co. | COM | 27,882 | $153.4K | 0.3% | −12,519−31.0% | Reduced | History |
| CGEMCullinan Therapeutics, Inc. | COM | 13,516 | $145.4K | 0.3% | −6,758−33.3% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 10,249 | $136.3K | 0.3% | 00.0% | Unchanged | History |
| FIRYFiry Inc. | COM | 13,696 | $124.6K | 0.2% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| MVLAMovella Holdings Inc. | COM | 55,528 | $118.3K | 0.2% | −42−0.1% | Reduced | History |
| CRBUCaribou Biosciences, Inc. | COM | 20,714 | $88.0K | 0.2% | −6,905−25.0% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 25,811 | $87.8K | 0.2% | −8,604−25.0% | Reduced | History |
| PRDSPardes Biosciences, Inc. | COM | 35,923 | $65.0K | 0.1% | −20,978−36.9% | Reduced | History |
| MKULMolekule Group, Inc. | COM | 21,247 | $49.7K | 0.1% | +21,247 | New | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 18,025 | $24.7K | <0.1% | −8,917−33.1% | Reduced | History |
| VEROVenus Concept Inc. | COM | 10,667 | $22.7K | <0.1% | 00.0% | UnchangedConverted for a 1-for-15 split | History |
| GRNAGreenLight Biosciences Holdings, PBC | COMMON STOCK | 16,950 | $5.08K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (6)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| FROGJFrog Ltd | Stock | 95,251 | $1.88M | 3.6% | History |
| PATHUiPath, Inc. | Stock | 45,029 | $790.7K | 1.5% | History |
| KNTEKinnate Biopharma Inc. | COM | 15,588 | $97.4K | 0.2% | History |
| NOGNNogin, Inc. | COM | 21,220 | $57.6K | 0.1% | History |
| MLMoneylion Inc. | CL A | 74,573 | $42.3K | 0.1% | History |
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 29,320 | $12.8K | <0.1% | History |